These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1775272)

  • 1. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
    Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
    Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
    Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemocompatibility of extracorporeal circulation technique with autooxygenation: influence on platelet function and homologous blood requirement.
    Wojnar J; Bochenek A; Wnuk-Wojnar AM; Religa Z; Hołowiecki J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):875-85. PubMed ID: 1713895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
    van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators.
    Edmunds LH; Ellison N; Colman RW; Niewiarowski S; Rao AK; Addonizio VP; Stephenson LW; Edie RN
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):805-12. PubMed ID: 7087507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility of extracorporeal circulation with autooxygenation.
    Bochenek A; Religa Z; Kokot F; Wnuk-Wojnar AM; Wojnar J; Wnuk R; Gallert G; Skiba J
    Eur J Cardiothorac Surg; 1992; 6(8):397-402. PubMed ID: 1389244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
    Peterson KA; Dewanjee MK; Kaye MP
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):39-43. PubMed ID: 7087539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial.
    Pappalardo F; Della Valle P; Crescenzi G; Corno C; Franco A; Torracca L; Alfieri O; Galli L; Zangrillo A; D'Angelo A
    Ann Thorac Surg; 2006 Mar; 81(3):886-91. PubMed ID: 16488689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of a heparin-bonded membrane oxygenator (Carmeda MAXIMA) during the first 90 minutes of cardiopulmonary bypass: clinical comparison with the conventional system.
    Shigemitsu O; Hadama T; Takasaki H; Mori Y; Kimura T; Miyamoto S; Sako H; Soeda T; Kawawaki Y; Uchida Y
    Artif Organs; 1994 Dec; 18(12):936-41. PubMed ID: 7887832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation.
    Tamiya T; Maeo Y; Okada T; Ogoshi S; Fujimoto S; Yasui H
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):78-86. PubMed ID: 1728718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement.
    Castiglioni A; Verzini A; Pappalardo F; Colangelo N; Torracca L; Zangrillo A; Alfieri O
    Ann Thorac Surg; 2007 Feb; 83(2):586-91. PubMed ID: 17257992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of sevoflurane is reduced in plasma-tight compared to conventional membrane oxygenators.
    Prasser C; Zelenka M; Gruber M; Philipp A; Keyser A; Wiesenack C
    Eur J Anaesthesiol; 2008 Feb; 25(2):152-7. PubMed ID: 17655810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood compatibility of two different types of membrane oxygenator during cardiopulmonary bypass in infants.
    Gu YJ; Boonstra PW; Akkerman C; Mungroop H; Tigchelaar I; Van Oeveren W
    Int J Artif Organs; 1994 Oct; 17(10):543-8. PubMed ID: 7896428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a silicone coated hollow fiber oxygenator.
    Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
    ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass.
    Ereth MH; Nuttall GA; Clarke SH; Dearani JA; Fiechtner BK; Rishavy CR; Buda DA; Shaw TA; Orszulak TA; Oliver WC
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):545-50; discussion 539-41. PubMed ID: 11687991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
    Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.